Showing 1661-1670 of 2192 results for "".
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0806PainManagement-pdf/31287/Complex Regional Pain Syndrome (CRPS) presents significant challenges in long-term pain management, as demonstrated in Charles Argoff, MD’s article in Practical Neurology. CRPS is categorized into Type I (formerly Reflex Sympathetic Dystrophy) and Type II (formerly Causalgia). While both types share
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0606Epilepsy-pdf/31304/Epilepsy patients face a significantly elevated risk of skeletal fractures, estimated to be two to seven times higher than in individuals without epilepsy. This increased vulnerability is attributed to multiple factors, including the direct impact of seizures, fall-related injuries during seizure ep
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0606PainManagement-pdf/31306/Discography: Essential Insights for Neurologists in Chronic Back Pain ManagementChronic back pain poses significant challenges in neurology, and discography has re-emerged as a valuable diagnostic and therapeutic procedure for effective pain management. In his detailed examination, Charles Argoff, M
- Savvy Contracting Strategies for Clinical Research Trialshttps://practicalneurology.com/columns/practice-management/savvy-contracting-strategies-for-clinical-research-trials/31310/Participating in clinical trials offers neurologists the opportunity to advance medical knowledge, provide patients with access to innovative treatments, and generate additional revenue for their practices. However, engaging in clinical research involves navigating various challenges to ensure profi
- Rethinking the Safety of Stimulants in ADHDhttps://practicalneurology.com/columns/practice-management/rethinking-the-safety-of-stimulants-in-adhd/31322/Cardiovascular Safety of Stimulants in ADHD Treatment: An Update for CliniciansThe use of stimulants in treating Attention-Deficit/Hyperactivity Disorder (ADHD) has long been a cornerstone in managing this pervasive condition, which affects 5-7% of school-aged children and 3-5% of adults. However, r
- What Will Be Tysabri's Fate?https://practicalneurology.com/columns/practice-management/what-will-be-tysabris-fate/31328/Natalizumab (Tysabri) in Multiple Sclerosis: Breakthroughs and ChallengesOver the past decades, advancements in understanding multiple sclerosis (MS) pathogenesis have paved the way for targeted therapies aimed at disrupting the inflammatory processes that drive central nervous system (CNS) inflamma
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0306painmanagement-pdf/31338/Despite significant advancements in pain assessment and treatment modalities, both acute and chronic pain remain frequently undertreated in clinical practice. Contributing factors include patient underreporting and clinicians' uncertainties regarding current literature and standardized practices. To
- Pregnancy Prevention in Epilepsy: Assessing the Optionshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0206PregnancyEpilepsy-pdf/31346/Epilepsy significantly affects the quality of life for women, particularly in areas of professional, academic, and social functioning. For women of childbearing age, managing epilepsy intersects critically with family planning and reproductive health decisions. However, there is a notable gap in the
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0106dementia-pdf/31352/Alzheimer’s disease (AD) significantly disrupts sleep patterns, affecting nearly half of community-dwelling patients. These sleep disturbances not only impair the quality of life for patients but also impose a considerable burden on caregivers, often leading to decisions to transition patients to nu
- Endarterectomy is Still the Optimal Treatment for Asymptomatic Atherosclerosishttps://practicalneurology.com/columns/practice-management/endarterectomy-is-still-the-optimal-treatment-for-asymptomatic-atherosclerosis/31410/Carotid Endarterectomy in Asymptomatic Carotid Stenosis: Evaluating Surgical Expertise and OutcomesThe management of severe asymptomatic carotid stenosis has long centered on the efficacy of carotid endarterectomy (CEA). Recent insights emphasize that patient outcomes are significantly influenced by